Agilent Technologies (A) Return on Capital Employed (2011 - 2026)
Agilent Technologies (A) posted quarterly Return on Capital Employed of 14.57% for Q2 2026, up 44.0% year-over-year from 10.12% in Q2 2025, and up 5.46% sequentially from 13.82% in Q1 2026.
Agilent Technologies (A) Return on Capital Employed (2011 - 2026) Analysis & Trends
Agilent Technologies has disclosed Return on Capital Employed across 16 years of filings, most recently posting 14.57% for Q2 2026.
- For the quarter ending Q2 2026, Return on Capital Employed rose 44.0% year-over-year to 14.57%; the trailing twelve-month figure through Apr 2026 stood at 14.57% (up 44.0% YoY), and the FY2025 full-year result was 14.88%, down 93.0% from the prior year.
- Return on Capital Employed was 14.57% for Q2 2026 at Agilent Technologies, up from 13.82% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 18.98% in Q1 2023 and troughed at 13.82% in Q1 2026.
- The 5-year median for Return on Capital Employed is 15.21% (2022), against an average of 15.83%.
- Year-over-year, Return on Capital Employed jumped 365 bps in 2022 and slumped 482 bps in 2024.
- Year by year, Return on Capital Employed stood at 18.71% in 2022, then declined by 21 bps to 14.81% in 2023, then increased by 5 bps to 15.62% in 2024, then slipped by 7 bps to 14.6% in 2025, then fell by 0 bps to 14.57% in 2026.
- Per Business Quant, the three latest A Return on Capital Employed figures stand at 14.57% (Q2 2026), 13.82% (Q1 2026), and 14.6% (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 11.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 14.57% |
| Jan 31, 2026 | 13.82% |
| Oct 31, 2025 | 14.60% |
| Jul 31, 2025 | 14.02% |
| Apr 30, 2025 | 14.14% |
| Jan 31, 2025 | 14.78% |
| Oct 31, 2024 | 15.62% |
| Jul 31, 2024 | 17.43% |
| Apr 30, 2024 | 14.40% |
| Jan 31, 2024 | 14.16% |
| Oct 31, 2023 | 14.81% |
| Jul 31, 2023 | 15.75% |
| Apr 30, 2023 | 18.40% |
| Jan 31, 2023 | 18.98% |
| Oct 31, 2022 | 18.71% |
| Jul 31, 2022 | 18.00% |
| Apr 30, 2022 | 17.10% |
| Jan 31, 2022 | 15.62% |
| Oct 31, 2021 | 15.15% |
| Jul 31, 2021 | 14.35% |